Ba^(2+)pre-crosslinked carrageenan fiber(Ba/CAF)was prepared by adding a small amount of Ba^(2+) to the carrageenan(CA)solution as the spinning solution.Ba/CAF-n/A,Ba/CAF-n/B and Ba/CAF-n/C were prepared with ethanol ...Ba^(2+)pre-crosslinked carrageenan fiber(Ba/CAF)was prepared by adding a small amount of Ba^(2+) to the carrageenan(CA)solution as the spinning solution.Ba/CAF-n/A,Ba/CAF-n/B and Ba/CAF-n/C were prepared with ethanol solution(combine A),high concentration BaCl_(2)solution(combine B)and low concentration BaCl_(2)solution(combine C),as coagulation bath and stretch bath,respectively.The combination of coagulation bath and stretch bath suitable for Ba^(2+) pre-crosslinking wet spinning was screened.The results showed that Ba^(2+) can induce the birefringence of the CA molecular chain,and the Ba^(2+) pre-crosslinking effect is the best when the CA mass fraction is 8.0 wt%.From the perspective of production safety,fiber performance and spinning cost,the coagulation bath of 3.5 wt%BaCl_(2)solution and stretch bath of 1.7 wt%BaCl_(2)solution,that is,combination C with low concentration BaCl_(2)solution,is the best choice.Ba/CAF-8.0/C was obtained under the best conditions.The linear intensity,water absorption and flame retardancy study showed that the breaking strength of Ba/CAF-8.0/C is as high as 1.61 cN/dtex,the water absorption was 649.2%and 574.3%,in deionized water and normal saline,respectively,and the LOI value reached 32.展开更多
目的探讨临床诊治气阴两虚夹痰瘀证肥胖2型糖尿病患者时予以乌梅丸合八珍汤的价值。方法选取2022年6月—2023年6月福建省厦门市同安区中医医院收治的100例气阴两虚夹痰瘀证肥胖2型糖尿病患者为研究对象。采用随机数表法分成两组,各50例...目的探讨临床诊治气阴两虚夹痰瘀证肥胖2型糖尿病患者时予以乌梅丸合八珍汤的价值。方法选取2022年6月—2023年6月福建省厦门市同安区中医医院收治的100例气阴两虚夹痰瘀证肥胖2型糖尿病患者为研究对象。采用随机数表法分成两组,各50例。对照组行二甲双胍常规治疗,观察组结合乌梅丸合八珍汤治疗。对比两组临床疗效、血糖水平、体重指数(body mass index,BMI)、不良反应发生率。结果观察组治疗总有效率(96.00%)高于对照组(82.00%),差异有统计学意义(χ^(2)=5.005,P=0.025)。治疗前两组血糖水平和BMI值相比,差异无统计学意义(P均>0.05)。治疗后,观察组上述指标均低于对照组,差异有统计学意义(P均<0.05)。两组不良反应发生率相比,差异无统计学意义(P>0.05)。结论通过采取乌梅丸合八珍汤治疗方法,可以在气阴两虚夹痰瘀证肥胖2型糖尿病患者中产生显著的预后效果,在降低血糖和BMI值方面具有明显优势,药物不良反应少。展开更多
基金supported by the Program of the National Natural Science Foundation of China(52173037)Natural Science Foundation of Shandong Province(ZR2020ME061)+1 种基金State Key Laboratory of Bio-Fibers and Eco-Textiles of Qingdao University(ZFT201810,ZKT17,TSKT202107)the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China(IRT14R30).
文摘Ba^(2+)pre-crosslinked carrageenan fiber(Ba/CAF)was prepared by adding a small amount of Ba^(2+) to the carrageenan(CA)solution as the spinning solution.Ba/CAF-n/A,Ba/CAF-n/B and Ba/CAF-n/C were prepared with ethanol solution(combine A),high concentration BaCl_(2)solution(combine B)and low concentration BaCl_(2)solution(combine C),as coagulation bath and stretch bath,respectively.The combination of coagulation bath and stretch bath suitable for Ba^(2+) pre-crosslinking wet spinning was screened.The results showed that Ba^(2+) can induce the birefringence of the CA molecular chain,and the Ba^(2+) pre-crosslinking effect is the best when the CA mass fraction is 8.0 wt%.From the perspective of production safety,fiber performance and spinning cost,the coagulation bath of 3.5 wt%BaCl_(2)solution and stretch bath of 1.7 wt%BaCl_(2)solution,that is,combination C with low concentration BaCl_(2)solution,is the best choice.Ba/CAF-8.0/C was obtained under the best conditions.The linear intensity,water absorption and flame retardancy study showed that the breaking strength of Ba/CAF-8.0/C is as high as 1.61 cN/dtex,the water absorption was 649.2%and 574.3%,in deionized water and normal saline,respectively,and the LOI value reached 32.
文摘目的探讨临床诊治气阴两虚夹痰瘀证肥胖2型糖尿病患者时予以乌梅丸合八珍汤的价值。方法选取2022年6月—2023年6月福建省厦门市同安区中医医院收治的100例气阴两虚夹痰瘀证肥胖2型糖尿病患者为研究对象。采用随机数表法分成两组,各50例。对照组行二甲双胍常规治疗,观察组结合乌梅丸合八珍汤治疗。对比两组临床疗效、血糖水平、体重指数(body mass index,BMI)、不良反应发生率。结果观察组治疗总有效率(96.00%)高于对照组(82.00%),差异有统计学意义(χ^(2)=5.005,P=0.025)。治疗前两组血糖水平和BMI值相比,差异无统计学意义(P均>0.05)。治疗后,观察组上述指标均低于对照组,差异有统计学意义(P均<0.05)。两组不良反应发生率相比,差异无统计学意义(P>0.05)。结论通过采取乌梅丸合八珍汤治疗方法,可以在气阴两虚夹痰瘀证肥胖2型糖尿病患者中产生显著的预后效果,在降低血糖和BMI值方面具有明显优势,药物不良反应少。
基金Supported by the National Natural Science Foundation of China(11204001,11174004)Anhui Provincial Natural Science Foundation(1208085QA07,1308085MA04)+2 种基金the Higher Educational Natural Science Foundation of Anhui Province(KJ2013A031)Anhui University Scientific Research Fund(201410357005,KYXL2013009)“211 Project”of Anhui University(SZJYKC2013020,XJGXKC1401)